RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES

Apte, Zachary S.; Richman, Jessica; Almonacid, Daniel; Marquez, Valeria; Araya, Ingrid; Alegria, Melissa; Saavedra, Mario; Gomez, Luis; Espinoza, Janyra; Gimpel, Javier; Morales, Eduardo.; Ortiz, Rodrigo

Abstract

Embodiments of a method and/or system can include administering, to a patient with one or more conditions associated with at least one of TMA, TMAO, and/or derivatives thereof, a therapeutically effective amount of a compound for affecting inhibiting one or more CutC enzymes and/or CntA enzymes associated with microorganisms from at least one taxon from a set of microorganism taxa.

Más información

URL: http://appft1.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PG01&p=1&u=/netahtml/PTO/srchnum.html&r=1&f=G&l=50&s1=20190050525.PGNR.&OS=DN/20190050525&RS=DN/20190050525
DOI:

US2019050525

Notas: United States Patent Application